Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.38 USD | +1.79% | -4.67% | +15.23% |
04-18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
04-18 | Verastem Oncology Announces Executive Changes | CI |
Business Summary
Number of employees: 73
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dan Paterson
CEO | Chief Executive Officer | 63 | 31/12/10 |
Daniel Calkins
DFI | Director of Finance/CFO | 37 | 30/11/18 |
Jonathan Pachter
CTO | Chief Tech/Sci/R&D Officer | 66 | 30/06/11 |
Brian Stuglik
BRD | Director/Board Member | 64 | 01/09/17 |
Michael Crowther
PRN | Corporate Officer/Principal | - | 25/10/23 |
Corporate Officer/Principal | 67 | 18/01/17 | |
Cathy Carew
PRN | Corporate Officer/Principal | - | - |
David Mitchell
LAW | General Counsel | 67 | 25/10/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 67 | 02/05/17 |
John Johnson
BRD | Director/Board Member | 66 | 22/04/20 |
Michael Kauffman
CHM | Chairman | 60 | 25/11/12 |
Dan Paterson
CEO | Chief Executive Officer | 63 | 31/12/10 |
Paul Bunn
BRD | Director/Board Member | 79 | 23/06/21 |
Anil Kapur
BRD | Director/Board Member | 54 | 19/10/22 |
Robert Gagnon
BRD | Director/Board Member | 49 | 12/12/22 |
Karin Tollefson
BRD | Director/Board Member | 57 | 14/05/23 |
Brian Stuglik
BRD | Director/Board Member | 64 | 01/09/17 |
Director/Board Member | 57 | 14/11/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,307,669 | 25,163,000 ( 99.43 %) | 0 | 99.43 % |
Stock B | 0 | 1,200,000 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.23% | 237M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VSTM Stock
- Company Verastem, Inc.